Recombinant Human GPR17 Protein，GST

GPR17 is a G protein-coupled receptor that has garnered significant attention in recent years due to its potential roles in various physiological and pathological processes, including myelination, neuroinflammation, and neurodegenerative diseases. It is notable for its dual activity, serving as a sensor for both purines and lipids, which places it at the intersection of metabolic and signal transduction pathways. Studies have indicated that GPR17 can modulate oligodendrocyte differentiation and myelin formation, highlighting its relevance in neurodevelopment and repair mechanisms following injury. Additionally, its involvement in the regulation of inflammatory responses suggests a potential therapeutic target for conditions like multiple sclerosis and other neuroinflammatory disorders. Given the receptor's multifaceted roles, the production and characterization of recombinant GPR17 protein are critical for elucidating its biological functions and mechanisms of action. Recombinant GPR17 proteins can be utilized in various experimental approaches, such as binding assays and functional assays, to explore ligand-receptor interactions and downstream signaling pathways. This research may pave the way for the development of novel therapeutic interventions targeting GPR17 in neurological diseases, thereby contributing to the broader understanding of receptor biology and its implications in health and disease. The ongoing investigation into GPR17 not only highlights its significance in the nervous system but also underscores the importance of receptor research in developing targeted therapies for complex disorders.